Synthesis and investigation of anticancer potential of radiolabeled naphthalene monoimide bearing imidazolium salt
dc.contributor.author | Lambrecht, Fatma Yurt | |
dc.contributor.author | Ocakoglu, Kasim | |
dc.contributor.author | Colak, Suleyman Gokhan | |
dc.contributor.author | Ersoz, Onur Alp | |
dc.contributor.author | Er, Ozge | |
dc.date.accessioned | 2019-10-27T11:07:04Z | |
dc.date.available | 2019-10-27T11:07:04Z | |
dc.date.issued | 2017 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Imidazolium salts and derivatives have antitumor efficacy and toxic effects in different micro-organisms. In this study, an imidazolium bromide salt (NMI) was synthesized, and its antitumor potential was investigated by in vitro studies. Radiolabeling of synthesized NMI was carried out by iodogen method using I-131 radionuclide. The yield of radiolabeling was determined as 98.5 +/- 0.1%. After that, cytotoxicity and intracellular uptake studies were evaluated in various cell lines. The cytotoxicity of NMI was determined as 35, 20, 10, and 1 mu m for HEK-293, PC-3, CaCo-2, and MCF-7 cells, respectively. In addition, the intracellular uptake of I-131-NMI was investigated in the cell lines, and the uptake was significantly found as 4 hr for MCF-7 and 6 hr for PC-3. In future studies, antitumor efficacy of I-131-NMI on tumor-bearing animal model might be studied in light of these results. | en_US |
dc.description.sponsorship | Department of Scientific Projects at Ege University, Izmir, TurkeyEge University [BAP 14 NBE007] | en_US |
dc.description.sponsorship | Department of Scientific Projects at Ege University, Izmir, Turkey, Grant/Award Number: (BAP 14 NBE007). | en_US |
dc.identifier.doi | 10.1111/cbdd.12935 | en_US |
dc.identifier.endpage | 146 | en_US |
dc.identifier.issn | 1747-0277 | |
dc.identifier.issn | 1747-0285 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 28067001 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 141 | en_US |
dc.identifier.uri | https://doi.org/10.1111/cbdd.12935 | |
dc.identifier.uri | https://hdl.handle.net/11454/31971 | |
dc.identifier.volume | 90 | en_US |
dc.identifier.wos | WOS:000405102600012 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Chemical Biology & Drug Design | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | I-131 | en_US |
dc.subject | anticancer potential | en_US |
dc.subject | imidazolium salts | en_US |
dc.subject | nuclear medicine | en_US |
dc.subject | Radiolabeling | en_US |
dc.title | Synthesis and investigation of anticancer potential of radiolabeled naphthalene monoimide bearing imidazolium salt | en_US |
dc.type | Article | en_US |